12.05.19
Kaneka has extended the deadline for participation in the first phase of its Innovation Award Program to Dec. 27. The free contest giveaway is an incentive for innovative brands to launch Floradapt finished product formulations onto their line. The second phase will be announced at Expo West in 2020.
Kaneka will provide the opportunity for nine contest winners to receive up to 5,000 free units of one of the three key Floradapt products: Baby Colic, Cardio, and Intensive GI probiotic finished product.
The campaign is open to current and prospective corporate clients in the U.S. and Canada.
Entry into the contest can be done online at www.floradapt.com/contest.
All contest applications must be submitted by Dec. 27, 2019 Midnight PST. The winners will be announced on Jan. 6, 2020.
Floradapt’s patented and clinically tested probiotic strains come from sources around the world which have not been affected by western lifestyle, diet, or medicine. Therefore, these products provide highly bio-efficacious effects for various stages of life, according to the company.
Floradapt has an extensive bank of over 1,000 acid-resistant clinical strains for targeted health conditions including Cardio, Intensive GI, Digestive, Oral Health, Mature Immune Defense, Baby Colic, Urinary Tract and Vaginal Health.
“This innovative class of probiotics will open up new opportunities for product manufacturers to provide their end customer with safe, effective, and differentiated probiotics for a diverse array of health targets,” said Mike Kolifrath, vice president of the probiotics division. “We strongly believe in these products, their origins and their unique mechanisms of action.”
Kaneka will provide the opportunity for nine contest winners to receive up to 5,000 free units of one of the three key Floradapt products: Baby Colic, Cardio, and Intensive GI probiotic finished product.
The campaign is open to current and prospective corporate clients in the U.S. and Canada.
Entry into the contest can be done online at www.floradapt.com/contest.
All contest applications must be submitted by Dec. 27, 2019 Midnight PST. The winners will be announced on Jan. 6, 2020.
Floradapt’s patented and clinically tested probiotic strains come from sources around the world which have not been affected by western lifestyle, diet, or medicine. Therefore, these products provide highly bio-efficacious effects for various stages of life, according to the company.
Floradapt has an extensive bank of over 1,000 acid-resistant clinical strains for targeted health conditions including Cardio, Intensive GI, Digestive, Oral Health, Mature Immune Defense, Baby Colic, Urinary Tract and Vaginal Health.
“This innovative class of probiotics will open up new opportunities for product manufacturers to provide their end customer with safe, effective, and differentiated probiotics for a diverse array of health targets,” said Mike Kolifrath, vice president of the probiotics division. “We strongly believe in these products, their origins and their unique mechanisms of action.”
